Laos vs Vietnam: Cause of death, by non-communicable diseases, ages 5-14, female
Laos
35.3%
in 2021
Vietnam
35.7%
in 2021
Laos rank
109th
Vietnam rank
108th
Cause of death, by non-communicable diseases, ages 5-14, female over time
- Laos
- Vietnam
How they compare
Vietnam currently reports 35.7% against 35.3% in Laos, a difference of 0.4%.
Across all 6 years both countries report, Vietnam has been ahead every year.
Laos ranks 109th and Vietnam ranks 108th of 184 countries.
Vietnam has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Laos | Vietnam | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.2% | 24.9% | 3.7% | Vietnam |
| 2010s | 31.3% | 33.6% | 2.3% | Vietnam |
| 2020s | 35.1% | 36.0% | 0.8% | Vietnam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, female, Laos or Vietnam?
- Vietnam, at 35.7% against 35.3% in Laos as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, female between Laos and Vietnam?
- 0.4%, with Vietnam ahead.
- How many years of comparable data are there for Laos and Vietnam?
- 6 years are reported by both, from 2000 to 2021.
- How do Laos and Vietnam rank globally for cause of death, by non-communicable diseases, ages 5-14, female?
- Laos ranks 109th and Vietnam ranks 108th of 184 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, female (% of total female deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 5-14 due to non-communicable diseases divided by number of all female deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.